Related Experiment Video
Updated: Aug 15, 2026

08:53
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
Xenon washout during in-vitro extracorporeal circulation using different oxygenators
Uwe Schirmer1, Helmut Reinelt, Matthias Erber
1Department of Cardiac Anesthesia , University of Ulm, D-89075 Ulm, Germany.
Journal of Clinical Monitoring and Computing
|November 29, 2002
Summary
Xenon anesthesia is not practical during extracorporeal circulation (ECC) because common oxygenators eliminate the anesthetic gas. Significant xenon loss occurs, making continuous application prohibitively expensive.
Area of Science:
- Anesthesiology
- Cardiovascular Surgery
- Medical Engineering
Background:
- Xenon anesthesia preserves myocardial contractility and cardiocirculatory function, even in compromised patients.
- Its potential benefits for cardiac surgery patients undergoing extracorporeal circulation (ECC) are hindered by potential xenon loss.
- Investigating xenon diffusion through oxygenators is crucial to assess its feasibility during ECC.
Purpose of the Study:
- To determine if common oxygenators used in extracorporeal circulation (ECC) allow xenon to diffuse through.
- To quantify xenon loss during ECC when using standard oxygenators.
- To evaluate the practicality of using xenon anesthesia during ECC.
Main Methods:
- An in-vitro extracorporeal circulation (ECC) model was used with xenon-saturated blood.
- Eight experiments were conducted, testing four different common oxygenators.
- Continuous mass spectrometry at the exhaust port measured xenon concentrations in expired gas.
Main Results:
- Xenon concentrations peaked at the oxygenator exhaust within one minute of ECC initiation.
- No measurable xenon was detected in the expired gas two minutes after ECC onset.
- Common oxygenators effectively eliminate xenon during ECC.
Conclusions:
- Standard oxygenators lead to significant xenon elimination into the atmosphere during ECC.
- Maintaining xenon anesthesia during ECC would require continuous, costly gas application to offset losses.
- Current oxygenators and ECC equipment are not practical for xenon anesthesia in cardiac surgery.

